Subscribe to Newsletter

Subspecialties

Subspecialties Professional Development

Not All Big Pharma Loves Ophtho

| Mark Hillen

While other pharmaceutical companies are buying into ophthalmology, Pfizer is heading for the hills

Subspecialties Retina

Achieving Consensus on the Treatment of DME with ILUVIEN®

Who should receive ILUVIEN® for the treatment of chronic DME-associated vision impairment

Subspecialties Retina

Treating Macular Edema Following RVO

| Marianne Shahsuvaryan

The last decade has seen some great advances, but there's still room for improvement…

Subspecialties Retina

Predicting Anti-VEGF Treatment Outcomes

| Sebastian Waldstein

Predicting treatment outcomes manages their expectations and improves your care.

Subspecialties Retina

Loss of Traction

| Mark Hillen

If you had VMT or MH and could avoid vitrectomy, you would. Might ocriplasmin let you?

Subspecialties Retina

Gazing into the MYRROR

| Mark Hillen

Bayer and Regeneron have presented the phase III trial data for aflibercept treatment of myopic choroidal neovascularization

Subspecialties Business and Innovation

Smart(phone) Ophthalmoscopy

| Mark Hillen

An iPhone, an app, and a 20 D lens, along with a bit of practice, will get you fundus photographs in a pinch

Subspecialties Glaucoma

The Pill and Glaucoma

| Richard Gallagher

Two studies have found a link between long-term usage of contraceptive pills and glaucoma

Subspecialties Glaucoma

Blindingly Obvious Progress

| Mark Hillen

Analysis of a rich long-term epidemiological dataset reveals that interventions have significantly reduced the probability of open-angle glaucoma-related blindness

Subspecialties Cornea / Ocular Surface

A Shock to the System

| Florian Gekeler

Can transcorneal electrical stimulation help reverse retinal degeneration in retinitis pigmentosa? Ongoing clinical trials suggest that it may.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: